In the early days, we furiously scrubbed, afraid we could get sick from the virus lingering on objects and surfaces. What do we know now?
An enormous new data set peers into the health of the world’s population before 2020—and how the coronavirus turned that into a global disaster.
The CDC put out a central playbook for how to distribute the shots. But how states will address these guidelines is anything but uniform.
Instead of shutting down all of New York City, this time officials are taking a block-by-block approach to home in on areas with increasing case numbers.
Due to data control concerns, tribal nations are not part of the “All of Us” DNA collection program. But that means missing out on its Covid-19 antibody testing.
Dozens of case reports have hinted that the coronavirus might trigger the onset of diabetes in people with no history of the disease.
Covid-19’s path through the president’s world is an epidemiological mystery. We know why it spread, but not if it spread via a single infectious event.
Some people get no symptoms or mild ones, and there are treatments for the severest cases. But the disease is risky for people who are older and overweight.
The pharma companies are all using different playbooks to test their Covid-19 shots, so the first team to claim victory may not have the best formula.
The Trump administration hasn’t created a comprehensive plan for battling the pandemic. Some researchers propose borrowing one from the past.